Follow
Haoyang Cheng
Haoyang Cheng
PhD Candidate, UMass Chan Medical School
Verified email at umassmed.edu
Title
Cited by
Cited by
Year
A split prime editor with untethered reverse transcriptase and circular RNA template
B Liu, X Dong, H Cheng, C Zheng, Z Chen, TC Rodríguez, SQ Liang, ...
Nature Biotechnology 40 (9), 1388-1393, 2022
932022
Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector
H Zhang, N Bamidele, P Liu, O Ojelabi, XD Gao, T Rodriguez, H Cheng, ...
GEN biotechnology 1 (3), 285-299, 2022
302022
Targeted genome editing with a DNA-dependent DNA polymerase and exogenous DNA-containing templates
B Liu, X Dong, C Zheng, D Keener, Z Chen, H Cheng, JK Watts, W Xue, ...
Nature Biotechnology, 1-7, 2023
92023
In Vivo Prime Editing by Lipid Nanoparticle Co-Delivery of Chemically Modified pegRNA and Prime Editor mRNA
Z Chen, K Kelly, H Cheng, X Dong, AK Hedger, L Li, EJ Sontheimer, ...
GEN Biotechnology 2 (6), 490-502, 2023
22023
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope
N Bamidele, H Zhang, X Dong, H Cheng, N Gaston, H Feinzig, H Cao, ...
Nature Communications 15 (1), 1458, 2024
12024
Drosophila adhesion GPCR Remoulade regulates axon growth, branching, and guidance by modulating Rac1 GTPase
X Yang, C Pan, M Ye, J Liang, H Cheng, Q Liang, S Huang, J Wang, ...
Journal of genetics and genomics= Yi chuan xue bao, S1673-8527 (23) 00242-4, 2023
12023
Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope
N Bamidele, H Zhang, X Dong, N Gaston, H Cheng, K Kelly, JK Watts, ...
bioRxiv, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–7